In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Catalent closes $500mm senior note sale

Executive Summary

Catalent Inc. privately sold $500mm in aggregate principal amount of 5% senior unsecured notes due 2027 priced at par. The company will use the proceeds to pay off outstanding borrowings and related fees under term loans from existing senior secured credit facilities.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
    • Synthesis Technologies, Production Processes
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
    • OTC, Consumer
  • Services
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Nonconvertible Debt

Related Companies

UsernamePublicRestriction

Register